PC
MRNA icon

Prairiewood Capital’s Moderna MRNA Stock Holding History

Prairiewood Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,317
Closed -$525K – 75
2023
Q2 		$525K Sell
4,317
-58
-1% -$7.74K 0.35% 50
2023
Q1 		$672K Buy
4,375
+12
+0.3% +$1.98K 0.46% 39
2022
Q4 		$784K Sell
4,363
-65
-1% -$10.6K 0.58% 35
2022
Q3 		$524K Buy
4,428
+233
+6% +$35.4K 0.43% 46
2022
Q2 		$599K Sell
4,195
-10
-0.2% -$1.43K 0.48% 38
2022
Q1 		$724K Buy
+4,205
New +$708K 0.51% 37

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Prairiewood Capital's MRNA Position: Q3 2023 in Review

Prairiewood Capital sold out of Moderna (MRNA) in Q3 2023, closing a stake of 4,317 shares — an estimated $525K sold.

Prairiewood Capital first reported a position in MRNA in Q1 2022 and held it in 6 quarters. The position peaked at $784K in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Prairiewood Capital reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Prairiewood Capital sold 4,317 Moderna shares in Q3 2023, an estimated $525K.
  • Prairiewood Capital first reported a position in Moderna in Q1 2022 and held it in 6 quarters.
  • Prairiewood Capital's Moderna position peaked at $784K in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Prairiewood Capital's 13F filing for Q3 2023, filed 12 Oct 2023.